Duane Hickling

TL;DR: The ability to diagnose, treat, and manage rUTI long-term has evolved due to additional insights into the pathophysiology of rutI, a new appreciation for the adverse effects of repetitive antimicrobial therapy, rising rates of bacterial antimicrobial resistance (AMR), and better reporting of the natural history and clinical outcomes of acute cystitis and rUTi.

TL;DR: This research presents a meta-analyses of FRCSCs and FHEA6 usage patterns over a 25-year period that shows clear trends in use and abuse and describes how these patterns can be changed over time.

TL;DR: Compromised CN function is a significant cause of erectile dysfunction development following prostatectomy and serves as the primary target for potential neuroprotective or regenerative strategies utilizing NGFs such as BDNF, GDF-5, and NTN, and/or targeted novel therapeutics modulating signaling pathways.

TL;DR: Intravesical Botox, bacterial interference and sacral neuromodulation show significant promise for the prevention of UTIs in higher risk NB patients and future, multi-center, randomized controlled trials are required.

TL;DR: Management of women with frequent symptomatic rUTI can be particularly vexing for both patients and their treating physicians, so available and promising management strategies are addressed.